Selected Aspects of Cell and Molecular Biology of In Vivo Biocompatibility
The biocompatibility of an implanted material or prosthetic device is a dynamic and two-way process that involves the time dependent effects of the host on the material and the material on the host. The implantation of any synthetic material initiates a wound healing mechanism that is characterized by the inflammatory response. However, the inflammatory response itself involves complex and highly regulated interactions between specific cells and various molecular mediators. An understanding of these interactions which occur following biomaterial implantation has been hindered by the difficulty in quantifying the cellular and biological events.
KeywordsGiant Cell Foreign Body Reaction Foreign Body Giant Cell Implantation Time Empty Cage
Unable to display preview. Download preview PDF.
- 2.J.M. Anderson, R.E. Marchant, S. Suzuki, K. Phua, C. Hamlin, A. Rabinovitch and A. Hiltner, In vivo biocompatibility studies. IV. Biomer® and the acute inflammatory response, in: “Polyurethanes in Medicine”, H. Planck, editor, in press.Google Scholar
- 3.J.M. Anderson, R.E. Marchant and M. McClurken, Tissue response to drug delivery systems: the cage implant system, in: “Long-Acting Contraceptive Delivery Systems”, G.I. Zatuchni et al., editors, Harper and Row, Inc., New York, in press.Google Scholar
- 4.C.W. Castor, Autocoid regulation of wound healing, in: “Tissue Repair and Regeneration”, L.E. Glynn, editor, Elsevier/North-Holland Biomedical Press, New York (1981).Google Scholar
- 5.D.G. Wright and J.I. Gallin, Secretory response of human neutrophils: exocytosis of specific (secondary) granules by human neutrophils during adherence in vitro and during exudation in vivo. J. Immunol. , 123: 285 (1979).Google Scholar
- 6.P.M. Henson, Mechanisms of exocytosis in phagocytic inflammatory cells. Am. J. Pathol. , 101: 494 (1980).Google Scholar
- 7.R.E. Marchant and J.M. Anderson, unpublished results.Google Scholar
- 9.I.M. Goldstein and H.D. Perez, Biologically active peptides derived from the fifth component of complement, in: “Progress in Hemostasis and Thrombosis”, Volume 5, T.M. Spaet, editor, Grune and Stratton, New York (1980).Google Scholar